Patents by Inventor Syed Kaleem Ahmed

Syed Kaleem Ahmed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus
    Patent number: 11905306
    Abstract: The present disclosure is concerned with substituted phenyl ethynyl pyridine carboxamide compounds, pharmaceutical compositions comprising the compounds, and methods of treating viral infections due to a Coronavirus such as, for example, Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus disease 2019 (SARS-CoV-2), using the compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: December 21, 2022
    Date of Patent: February 20, 2024
    Assignees: Southern Research Institute, Vanderbilt University, University of North Carolina at Chapel Hill
    Inventors: Syed Kaleem Ahmed, Shilpa Dutta, John Phillip Tillotson, Corinne E. Augelli-Szafran, Ashish Kumar Pathak, Omar Moukha-Chafiq, Timothy Patrick Sheahan, Ralph S. Baric, Amy Catherine Sims, Mark R. Denison
  • SUBSTITUTED PHENYL ET458HYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS
    Publication number: 20230192733
    Abstract: The present disclosure is concerned with substituted phenyl ethynyl pyridine carboxamide compounds, pharmaceutical compositions comprising the compounds, and methods of treating viral infections due to a Coronavirus such as, for example, Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus disease 2019 (SARS-CoV-2), using the compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 22, 2023
    Inventors: Syed Kaleem Ahmed, Shilpa Dutta, John Phillip Tillotson, Corinne E. Augelli-Szafran, Ashish Kumar Pathak, Omar Moukha-Chafiq, Timothy Patrick Sheahan, Ralph S. Baric, Amy Catherine Sims, Mark R. Denison
  • Benzoannulene derivatives as antiviral agents
    Patent number: 11066357
    Abstract: The present disclosure is concerned with benzoannulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: December 24, 2018
    Date of Patent: July 20, 2021
    Assignee: SOUTHERN RESEARCH INSTITUTE
    Inventors: Ashish Kumar Pathak, Syed Kaleem Ahmed, Mark J. Suto, Corinne E. Augelli-Szafran
  • BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS
    Publication number: 20210078937
    Abstract: The present disclosure is concerned with benzoannulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: December 24, 2018
    Publication date: March 18, 2021
    Inventors: Ashish Kumar Pathak, Syed Kaleem Ahmed, Mark J. Suto, Corinne E. Augelli-Szafran
  • 4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS
    Publication number: 20200399264
    Abstract: The present disclosure is concerned with benzoannulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, Eastern equine encephalitis, Western equine encephalitis, dengue, West Nile, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: June 15, 2020
    Publication date: December 24, 2020
    Inventors: Ashish Kumar Pathak, Corinne E. Augelli-Szafran, Syed Kaleem Ahmed, Atefeh Garzan, Daniel Streblow, Nicole Haese
  • Benzo annulenes as antiviral agents
    Patent number: 10450263
    Abstract: The present disclosure is concerned with benzo annulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: October 22, 2019
    Assignee: Southern Research Institute
    Inventors: Ashish Kumar Pathak, Syed Kaleem Ahmed, Corinne E. Augelli-Szafran, Joseph A. Maddry
  • Benzo Annulenes as Antiviral Agents
    Publication number: 20180230084
    Abstract: The present disclosure is concerned with benzo annulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: February 8, 2018
    Publication date: August 16, 2018
    Inventors: Ashish Kumar Pathak, Syed Kaleem Ahmed, Corinne E. Augelli-Szafran, Joseph A. Maddry